nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC6—Doxorubicin—thyroid cancer	0.141	0.18	CbGbCtD
Probenecid—ABCC1—Vandetanib—thyroid cancer	0.114	0.145	CbGbCtD
Probenecid—ABCC4—Sorafenib—thyroid cancer	0.0856	0.109	CbGbCtD
Probenecid—ABCC1—Epirubicin—thyroid cancer	0.0785	0.1	CbGbCtD
Probenecid—ABCC3—Doxorubicin—thyroid cancer	0.068	0.0866	CbGbCtD
Probenecid—ALB—Vandetanib—thyroid cancer	0.0526	0.0671	CbGbCtD
Probenecid—ABCC2—Sorafenib—thyroid cancer	0.0509	0.0649	CbGbCtD
Probenecid—ABCC1—Doxorubicin—thyroid cancer	0.0417	0.0532	CbGbCtD
Probenecid—ABCC2—Doxorubicin—thyroid cancer	0.0309	0.0394	CbGbCtD
Probenecid—Renal colic—Vandetanib—thyroid cancer	0.0246	0.298	CcSEcCtD
Probenecid—CYP2C8—Sorafenib—thyroid cancer	0.0245	0.0312	CbGbCtD
Probenecid—CYP2C19—Sorafenib—thyroid cancer	0.0206	0.0262	CbGbCtD
Probenecid—CYP2C9—Sorafenib—thyroid cancer	0.0171	0.0218	CbGbCtD
Probenecid—ABCB1—Sorafenib—thyroid cancer	0.0166	0.0211	CbGbCtD
Probenecid—CYP3A4—Vandetanib—thyroid cancer	0.0165	0.021	CbGbCtD
Probenecid—ABCB1—Doxorubicin—thyroid cancer	0.0101	0.0128	CbGbCtD
Probenecid—CYP3A4—Sorafenib—thyroid cancer	0.00995	0.0127	CbGbCtD
Probenecid—CYP3A4—Doxorubicin—thyroid cancer	0.00603	0.00769	CbGbCtD
Probenecid—Nephrotic syndrome—Sorafenib—thyroid cancer	0.0053	0.0644	CcSEcCtD
Probenecid—PANX1—trachea—thyroid cancer	0.00375	0.0762	CbGeAlD
Probenecid—PANX1—thyroid gland—thyroid cancer	0.00296	0.0603	CbGeAlD
Probenecid—SLC2A9—thyroid gland—thyroid cancer	0.00269	0.0546	CbGeAlD
Probenecid—PANX1—head—thyroid cancer	0.00263	0.0535	CbGeAlD
Probenecid—SLC16A7—saliva-secreting gland—thyroid cancer	0.0026	0.0528	CbGeAlD
Probenecid—Pollakiuria—Vandetanib—thyroid cancer	0.0022	0.0267	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00211	0.0256	CcSEcCtD
Probenecid—Haematuria—Vandetanib—thyroid cancer	0.00203	0.0246	CcSEcCtD
Probenecid—SLC16A7—trachea—thyroid cancer	0.002	0.0408	CbGeAlD
Probenecid—PANX1—lymph node—thyroid cancer	0.00184	0.0374	CbGeAlD
Probenecid—Erythema multiforme—Vandetanib—thyroid cancer	0.0018	0.0219	CcSEcCtD
Probenecid—Alopecia—Vandetanib—thyroid cancer	0.00169	0.0205	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00168	0.0203	CcSEcCtD
Probenecid—SLC2A9—lymph node—thyroid cancer	0.00167	0.0339	CbGeAlD
Probenecid—ABCC6—thyroid gland—thyroid cancer	0.00163	0.0332	CbGeAlD
Probenecid—SLC16A7—thyroid gland—thyroid cancer	0.00159	0.0322	CbGeAlD
Probenecid—ABCC6—head—thyroid cancer	0.00145	0.0294	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00142	0.0173	CcSEcCtD
Probenecid—SLC16A7—head—thyroid cancer	0.00141	0.0286	CbGeAlD
Probenecid—SLCO1C1—thyroid gland—thyroid cancer	0.00139	0.0283	CbGeAlD
Probenecid—SLC10A1—head—thyroid cancer	0.00131	0.0267	CbGeAlD
Probenecid—SLCO1C1—head—thyroid cancer	0.00124	0.0251	CbGeAlD
Probenecid—Erythema multiforme—Sorafenib—thyroid cancer	0.00122	0.0148	CcSEcCtD
Probenecid—Flushing—Sorafenib—thyroid cancer	0.00119	0.0145	CcSEcCtD
Probenecid—Decreased appetite—Vandetanib—thyroid cancer	0.00118	0.0143	CcSEcCtD
Probenecid—Pain—Vandetanib—thyroid cancer	0.00116	0.0141	CcSEcCtD
Probenecid—Alopecia—Sorafenib—thyroid cancer	0.00114	0.0138	CcSEcCtD
Probenecid—ABCC5—thyroid gland—thyroid cancer	0.00111	0.0226	CbGeAlD
Probenecid—Body temperature increased—Vandetanib—thyroid cancer	0.00107	0.013	CcSEcCtD
Probenecid—Anaemia—Sorafenib—thyroid cancer	0.00104	0.0126	CcSEcCtD
Probenecid—SLC16A1—thyroid gland—thyroid cancer	0.00101	0.0205	CbGeAlD
Probenecid—Leukopenia—Sorafenib—thyroid cancer	0.001	0.0122	CcSEcCtD
Probenecid—SLC16A7—lymph node—thyroid cancer	0.000985	0.02	CbGeAlD
Probenecid—Pruritus—Vandetanib—thyroid cancer	0.000959	0.0116	CcSEcCtD
Probenecid—SLC22A5—saliva-secreting gland—thyroid cancer	0.000945	0.0192	CbGeAlD
Probenecid—ABCC3—thyroid gland—thyroid cancer	0.000932	0.0189	CbGeAlD
Probenecid—Anaphylactic shock—Sorafenib—thyroid cancer	0.000914	0.0111	CcSEcCtD
Probenecid—Dizziness—Vandetanib—thyroid cancer	0.000896	0.0109	CcSEcCtD
Probenecid—SLC16A1—head—thyroid cancer	0.000895	0.0182	CbGeAlD
Probenecid—Aplastic anaemia—Epirubicin—thyroid cancer	0.000889	0.0108	CcSEcCtD
Probenecid—Anorexia—Sorafenib—thyroid cancer	0.000872	0.0106	CcSEcCtD
Probenecid—SLCO1C1—lymph node—thyroid cancer	0.000865	0.0176	CbGeAlD
Probenecid—Vomiting—Vandetanib—thyroid cancer	0.000862	0.0105	CcSEcCtD
Probenecid—Dermatitis—Vandetanib—thyroid cancer	0.000854	0.0104	CcSEcCtD
Probenecid—Headache—Vandetanib—thyroid cancer	0.000849	0.0103	CcSEcCtD
Probenecid—ABCC1—trachea—thyroid cancer	0.000829	0.0169	CbGeAlD
Probenecid—ABCC3—head—thyroid cancer	0.000826	0.0168	CbGeAlD
Probenecid—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000823	0.00999	CcSEcCtD
Probenecid—Nausea—Vandetanib—thyroid cancer	0.000805	0.00978	CcSEcCtD
Probenecid—Decreased appetite—Sorafenib—thyroid cancer	0.000795	0.00965	CcSEcCtD
Probenecid—Pain—Sorafenib—thyroid cancer	0.000782	0.00949	CcSEcCtD
Probenecid—ABCC4—thyroid gland—thyroid cancer	0.000769	0.0156	CbGeAlD
Probenecid—SLC22A1—head—thyroid cancer	0.000736	0.015	CbGeAlD
Probenecid—SLC22A5—trachea—thyroid cancer	0.000729	0.0148	CbGeAlD
Probenecid—Urticaria—Sorafenib—thyroid cancer	0.000726	0.00882	CcSEcCtD
Probenecid—Body temperature increased—Sorafenib—thyroid cancer	0.000723	0.00878	CcSEcCtD
Probenecid—SLCO1A2—head—thyroid cancer	0.000709	0.0144	CbGeAlD
Probenecid—ABCC5—lymph node—thyroid cancer	0.000689	0.014	CbGeAlD
Probenecid—ABCC4—head—thyroid cancer	0.000682	0.0139	CbGeAlD
Probenecid—SLC22A8—head—thyroid cancer	0.000677	0.0138	CbGeAlD
Probenecid—Hypersensitivity—Sorafenib—thyroid cancer	0.000674	0.00818	CcSEcCtD
Probenecid—ABCC1—thyroid gland—thyroid cancer	0.000656	0.0133	CbGeAlD
Probenecid—Pruritus—Sorafenib—thyroid cancer	0.000647	0.00786	CcSEcCtD
Probenecid—SLC16A1—lymph node—thyroid cancer	0.000627	0.0127	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000619	0.00752	CcSEcCtD
Probenecid—Dizziness—Sorafenib—thyroid cancer	0.000605	0.00734	CcSEcCtD
Probenecid—Vomiting—Sorafenib—thyroid cancer	0.000581	0.00706	CcSEcCtD
Probenecid—ABCC3—lymph node—thyroid cancer	0.000579	0.0118	CbGeAlD
Probenecid—SLC22A5—thyroid gland—thyroid cancer	0.000577	0.0117	CbGeAlD
Probenecid—Dermatitis—Sorafenib—thyroid cancer	0.000576	0.00699	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000573	0.00696	CcSEcCtD
Probenecid—Headache—Sorafenib—thyroid cancer	0.000573	0.00696	CcSEcCtD
Probenecid—Pollakiuria—Epirubicin—thyroid cancer	0.000549	0.00667	CcSEcCtD
Probenecid—Nausea—Sorafenib—thyroid cancer	0.000543	0.0066	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000525	0.00638	CcSEcCtD
Probenecid—Pollakiuria—Doxorubicin—thyroid cancer	0.000508	0.00617	CcSEcCtD
Probenecid—Haematuria—Epirubicin—thyroid cancer	0.000505	0.00613	CcSEcCtD
Probenecid—ALB—lymph node—thyroid cancer	0.000493	0.01	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000486	0.0059	CcSEcCtD
Probenecid—ABCC4—lymph node—thyroid cancer	0.000478	0.00971	CbGeAlD
Probenecid—Haematuria—Doxorubicin—thyroid cancer	0.000467	0.00568	CcSEcCtD
Probenecid—ABCC2—lymph node—thyroid cancer	0.000462	0.0094	CbGeAlD
Probenecid—Erythema multiforme—Epirubicin—thyroid cancer	0.00045	0.00546	CcSEcCtD
Probenecid—Flushing—Epirubicin—thyroid cancer	0.000441	0.00536	CcSEcCtD
Probenecid—Alopecia—Epirubicin—thyroid cancer	0.00042	0.0051	CcSEcCtD
Probenecid—Erythema multiforme—Doxorubicin—thyroid cancer	0.000416	0.00505	CcSEcCtD
Probenecid—Flushing—Doxorubicin—thyroid cancer	0.000408	0.00496	CcSEcCtD
Probenecid—ABCC1—lymph node—thyroid cancer	0.000407	0.00828	CbGeAlD
Probenecid—Alopecia—Doxorubicin—thyroid cancer	0.000389	0.00472	CcSEcCtD
Probenecid—Anaemia—Epirubicin—thyroid cancer	0.000383	0.00465	CcSEcCtD
Probenecid—Leukopenia—Epirubicin—thyroid cancer	0.000371	0.0045	CcSEcCtD
Probenecid—SLC22A5—lymph node—thyroid cancer	0.000358	0.00728	CbGeAlD
Probenecid—Anaemia—Doxorubicin—thyroid cancer	0.000354	0.0043	CcSEcCtD
Probenecid—Leukopenia—Doxorubicin—thyroid cancer	0.000343	0.00416	CcSEcCtD
Probenecid—ABCB1—trachea—thyroid cancer	0.000338	0.00688	CbGeAlD
Probenecid—Anaphylactic shock—Epirubicin—thyroid cancer	0.000338	0.0041	CcSEcCtD
Probenecid—Anorexia—Epirubicin—thyroid cancer	0.000322	0.00391	CcSEcCtD
Probenecid—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000313	0.0038	CcSEcCtD
Probenecid—Anorexia—Doxorubicin—thyroid cancer	0.000298	0.00362	CcSEcCtD
Probenecid—Decreased appetite—Epirubicin—thyroid cancer	0.000294	0.00357	CcSEcCtD
Probenecid—Pain—Epirubicin—thyroid cancer	0.000289	0.00351	CcSEcCtD
Probenecid—Decreased appetite—Doxorubicin—thyroid cancer	0.000272	0.0033	CcSEcCtD
Probenecid—Urticaria—Epirubicin—thyroid cancer	0.000268	0.00326	CcSEcCtD
Probenecid—ABCB1—thyroid gland—thyroid cancer	0.000268	0.00544	CbGeAlD
Probenecid—Pain—Doxorubicin—thyroid cancer	0.000267	0.00325	CcSEcCtD
Probenecid—Body temperature increased—Epirubicin—thyroid cancer	0.000267	0.00324	CcSEcCtD
Probenecid—Hypersensitivity—Epirubicin—thyroid cancer	0.000249	0.00302	CcSEcCtD
Probenecid—Urticaria—Doxorubicin—thyroid cancer	0.000248	0.00302	CcSEcCtD
Probenecid—Body temperature increased—Doxorubicin—thyroid cancer	0.000247	0.003	CcSEcCtD
Probenecid—Pruritus—Epirubicin—thyroid cancer	0.000239	0.0029	CcSEcCtD
Probenecid—ABCB1—head—thyroid cancer	0.000237	0.00483	CbGeAlD
Probenecid—Hypersensitivity—Doxorubicin—thyroid cancer	0.00023	0.0028	CcSEcCtD
Probenecid—Dizziness—Epirubicin—thyroid cancer	0.000223	0.00271	CcSEcCtD
Probenecid—Pruritus—Doxorubicin—thyroid cancer	0.000221	0.00269	CcSEcCtD
Probenecid—Vomiting—Epirubicin—thyroid cancer	0.000215	0.00261	CcSEcCtD
Probenecid—Dermatitis—Epirubicin—thyroid cancer	0.000213	0.00258	CcSEcCtD
Probenecid—Headache—Epirubicin—thyroid cancer	0.000212	0.00257	CcSEcCtD
Probenecid—Dizziness—Doxorubicin—thyroid cancer	0.000207	0.00251	CcSEcCtD
Probenecid—Nausea—Epirubicin—thyroid cancer	0.000201	0.00244	CcSEcCtD
Probenecid—Vomiting—Doxorubicin—thyroid cancer	0.000199	0.00241	CcSEcCtD
Probenecid—Dermatitis—Doxorubicin—thyroid cancer	0.000197	0.00239	CcSEcCtD
Probenecid—Headache—Doxorubicin—thyroid cancer	0.000196	0.00238	CcSEcCtD
Probenecid—Nausea—Doxorubicin—thyroid cancer	0.000186	0.00226	CcSEcCtD
Probenecid—ABCB1—lymph node—thyroid cancer	0.000166	0.00338	CbGeAlD
Probenecid—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	5.87e-05	0.000703	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.84e-05	0.000699	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.82e-05	0.000696	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—TPR—thyroid cancer	5.81e-05	0.000696	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	5.81e-05	0.000695	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.77e-05	0.000691	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.72e-05	0.000685	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PRKAR1A—thyroid cancer	5.72e-05	0.000684	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.67e-05	0.000678	CbGpPWpGaD
Probenecid—PANX1—Immune System—KRAS—thyroid cancer	5.6e-05	0.000671	CbGpPWpGaD
Probenecid—ABCC5—Disease—CALCA—thyroid cancer	5.59e-05	0.000669	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—HPGD—thyroid cancer	5.47e-05	0.000655	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.39e-05	0.000645	CbGpPWpGaD
Probenecid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	5.36e-05	0.000641	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MINPP1—thyroid cancer	5.33e-05	0.000638	CbGpPWpGaD
Probenecid—ALB—Metabolism—MINPP1—thyroid cancer	5.3e-05	0.000634	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—RXRA—thyroid cancer	5.13e-05	0.000614	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—HPGD—thyroid cancer	5.1e-05	0.000611	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.1e-05	0.00061	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.06e-05	0.000606	CbGpPWpGaD
Probenecid—ABCC5—Disease—CDK1—thyroid cancer	5.06e-05	0.000605	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.02e-05	0.000602	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.99e-05	0.000597	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.9e-05	0.000587	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.85e-05	0.00058	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—BRAF—thyroid cancer	4.83e-05	0.000578	CbGpPWpGaD
Probenecid—PANX1—Immune System—HRAS—thyroid cancer	4.76e-05	0.00057	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PRKAR1A—thyroid cancer	4.76e-05	0.000569	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MINPP1—thyroid cancer	4.75e-05	0.000569	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.68e-05	0.000561	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—SLC5A5—thyroid cancer	4.68e-05	0.00056	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MINPP1—thyroid cancer	4.64e-05	0.000556	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—TPR—thyroid cancer	4.61e-05	0.000552	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TP53—thyroid cancer	4.59e-05	0.000549	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PRKAR1A—thyroid cancer	4.53e-05	0.000543	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.53e-05	0.000542	CbGpPWpGaD
Probenecid—ALB—Metabolism—NDUFA13—thyroid cancer	4.5e-05	0.000539	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—BRAF—thyroid cancer	4.5e-05	0.000539	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—SLC5A5—thyroid cancer	4.35e-05	0.000521	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.33e-05	0.000519	CbGpPWpGaD
Probenecid—ABCC1—Disease—TPR—thyroid cancer	4.31e-05	0.000516	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CHST14—thyroid cancer	4.26e-05	0.00051	CbGpPWpGaD
Probenecid—ABCC1—Disease—PRKAR1A—thyroid cancer	4.24e-05	0.000508	CbGpPWpGaD
Probenecid—ALB—Metabolism—CHST14—thyroid cancer	4.23e-05	0.000507	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.22e-05	0.000505	CbGpPWpGaD
Probenecid—PANX1—Immune System—AKT1—thyroid cancer	4.21e-05	0.000504	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	4.18e-05	0.000501	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	4.18e-05	0.000501	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.12e-05	0.000493	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.11e-05	0.000492	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRG1—thyroid cancer	4.06e-05	0.000486	CbGpPWpGaD
Probenecid—ABCC1—Disease—MEN1—thyroid cancer	4.05e-05	0.000485	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.04e-05	0.000484	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—TPR—thyroid cancer	4.01e-05	0.00048	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	3.95e-05	0.000472	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NDUFA13—thyroid cancer	3.95e-05	0.000472	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.93e-05	0.000471	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—RXRA—thyroid cancer	3.93e-05	0.000471	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.89e-05	0.000466	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CHST14—thyroid cancer	3.8e-05	0.000455	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CHST14—thyroid cancer	3.71e-05	0.000444	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.69e-05	0.000441	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.67e-05	0.000439	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.67e-05	0.000439	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—RXRA—thyroid cancer	3.65e-05	0.000437	CbGpPWpGaD
Probenecid—ABCC5—Disease—TERT—thyroid cancer	3.64e-05	0.000436	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—TPR—thyroid cancer	3.61e-05	0.000432	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.61e-05	0.000432	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.58e-05	0.000428	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PRKAR1A—thyroid cancer	3.55e-05	0.000425	CbGpPWpGaD
Probenecid—ABCC5—Disease—HIF1A—thyroid cancer	3.48e-05	0.000417	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—NRAS—thyroid cancer	3.48e-05	0.000417	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CHST14—thyroid cancer	3.47e-05	0.000415	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—SLC5A5—thyroid cancer	3.45e-05	0.000413	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HPGD—thyroid cancer	3.43e-05	0.000411	CbGpPWpGaD
Probenecid—ALB—Metabolism—HPGD—thyroid cancer	3.41e-05	0.000409	CbGpPWpGaD
Probenecid—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.39e-05	0.000406	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	3.25e-05	0.00039	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PPARG—thyroid cancer	3.24e-05	0.000388	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.23e-05	0.000387	CbGpPWpGaD
Probenecid—ABCC1—Disease—CALCA—thyroid cancer	3.23e-05	0.000386	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.22e-05	0.000385	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IFNA2—thyroid cancer	3.15e-05	0.000377	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—TPR—thyroid cancer	3.14e-05	0.000376	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.13e-05	0.000375	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	3.09e-05	0.00037	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HPGD—thyroid cancer	3.06e-05	0.000367	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3e-05	0.00036	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—KRAS—thyroid cancer	3e-05	0.000359	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HPGD—thyroid cancer	2.99e-05	0.000358	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TPR—thyroid cancer	2.93e-05	0.000351	CbGpPWpGaD
Probenecid—ABCC1—Disease—CDK1—thyroid cancer	2.92e-05	0.00035	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—RXRA—thyroid cancer	2.9e-05	0.000347	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.9e-05	0.000347	CbGpPWpGaD
Probenecid—ABCC5—Disease—BRAF—thyroid cancer	2.89e-05	0.000345	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.88e-05	0.000345	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	2.88e-05	0.000345	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.86e-05	0.000342	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.82e-05	0.000337	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.81e-05	0.000337	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HPGD—thyroid cancer	2.79e-05	0.000334	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.78e-05	0.000333	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.77e-05	0.000331	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.74e-05	0.000329	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.7e-05	0.000324	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.7e-05	0.000323	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—thyroid cancer	2.66e-05	0.000319	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.63e-05	0.000315	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.61e-05	0.000312	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NRAS—thyroid cancer	2.6e-05	0.000311	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—HRAS—thyroid cancer	2.55e-05	0.000305	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTGS2—thyroid cancer	2.55e-05	0.000305	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.53e-05	0.000303	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—RXRA—thyroid cancer	2.52e-05	0.000302	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.52e-05	0.000301	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.48e-05	0.000297	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PPARG—thyroid cancer	2.48e-05	0.000297	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.45e-05	0.000294	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.43e-05	0.000291	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—SLC5A5—thyroid cancer	2.35e-05	0.000282	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRG1—thyroid cancer	2.34e-05	0.000281	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTGS2—thyroid cancer	2.33e-05	0.000279	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PPARG—thyroid cancer	2.31e-05	0.000276	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.31e-05	0.000276	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CHST14—thyroid cancer	2.29e-05	0.000274	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—RXRA—thyroid cancer	2.27e-05	0.000272	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.27e-05	0.000271	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—AKT1—thyroid cancer	2.25e-05	0.000269	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—KRAS—thyroid cancer	2.23e-05	0.000268	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—PTEN—thyroid cancer	2.22e-05	0.000266	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—HRAS—thyroid cancer	2.22e-05	0.000266	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.21e-05	0.000264	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.19e-05	0.000263	CbGpPWpGaD
Probenecid—ABCC1—Disease—TERT—thyroid cancer	2.1e-05	0.000252	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.07e-05	0.000248	CbGpPWpGaD
Probenecid—ABCC5—Disease—PTEN—thyroid cancer	2.03e-05	0.000243	CbGpPWpGaD
Probenecid—ABCC1—Disease—HIF1A—thyroid cancer	2.01e-05	0.000241	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—thyroid cancer	1.99e-05	0.000238	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—RXRA—thyroid cancer	1.98e-05	0.000237	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TPR—thyroid cancer	1.97e-05	0.000236	CbGpPWpGaD
Probenecid—ALB—Metabolism—TPR—thyroid cancer	1.96e-05	0.000235	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTGS2—thyroid cancer	1.95e-05	0.000234	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.94e-05	0.000232	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.93e-05	0.000231	CbGpPWpGaD
Probenecid—ALB—Metabolism—PRKAR1A—thyroid cancer	1.93e-05	0.000231	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—HRAS—thyroid cancer	1.9e-05	0.000227	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—RXRA—thyroid cancer	1.84e-05	0.000221	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HPGD—thyroid cancer	1.84e-05	0.000221	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PPARG—thyroid cancer	1.83e-05	0.000219	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTGS2—thyroid cancer	1.81e-05	0.000217	CbGpPWpGaD
Probenecid—ABCC5—Disease—NRAS—thyroid cancer	1.81e-05	0.000217	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TPR—thyroid cancer	1.76e-05	0.000211	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.76e-05	0.00021	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.75e-05	0.000209	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.73e-05	0.000207	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TPR—thyroid cancer	1.72e-05	0.000206	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.72e-05	0.000206	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PTEN—thyroid cancer	1.7e-05	0.000204	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.69e-05	0.000202	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—AKT1—thyroid cancer	1.68e-05	0.000201	CbGpPWpGaD
Probenecid—ABCC1—Disease—BRAF—thyroid cancer	1.67e-05	0.0002	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TPR—thyroid cancer	1.6e-05	0.000192	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.59e-05	0.000191	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PTEN—thyroid cancer	1.58e-05	0.000189	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.58e-05	0.000189	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.57e-05	0.000188	CbGpPWpGaD
Probenecid—ABCC5—Disease—KRAS—thyroid cancer	1.56e-05	0.000187	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.48e-05	0.000177	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	1.47e-05	0.000176	CbGpPWpGaD
Probenecid—ALB—Metabolism—SLC5A5—thyroid cancer	1.47e-05	0.000176	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.45e-05	0.000174	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTGS2—thyroid cancer	1.44e-05	0.000172	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PPARG—thyroid cancer	1.43e-05	0.000172	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.43e-05	0.000171	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.38e-05	0.000166	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.37e-05	0.000165	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—thyroid cancer	1.35e-05	0.000161	CbGpPWpGaD
Probenecid—ABCC5—Disease—HRAS—thyroid cancer	1.33e-05	0.000159	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000158	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000154	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—thyroid cancer	1.28e-05	0.000153	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PTEN—thyroid cancer	1.26e-05	0.00015	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.25e-05	0.00015	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—thyroid cancer	1.25e-05	0.000149	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—RXRA—thyroid cancer	1.24e-05	0.000148	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.23e-05	0.000148	CbGpPWpGaD
Probenecid—ALB—Metabolism—RXRA—thyroid cancer	1.23e-05	0.000148	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.21e-05	0.000144	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000144	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.2e-05	0.000144	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NRAS—thyroid cancer	1.17e-05	0.000141	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTEN—thyroid cancer	1.17e-05	0.000141	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—thyroid cancer	1.17e-05	0.00014	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—thyroid cancer	1.16e-05	0.000139	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—thyroid cancer	1.13e-05	0.000135	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.13e-05	0.000135	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—RXRA—thyroid cancer	1.11e-05	0.000132	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.09e-05	0.000131	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000129	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	0.000129	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TPR—thyroid cancer	1.06e-05	0.000127	CbGpPWpGaD
Probenecid—ABCC1—Disease—NRAS—thyroid cancer	1.05e-05	0.000125	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	0.000125	CbGpPWpGaD
Probenecid—ALB—Hemostasis—KRAS—thyroid cancer	1.01e-05	0.000121	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—RXRA—thyroid cancer	1.01e-05	0.000121	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTEN—thyroid cancer	9.83e-06	0.000118	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—thyroid cancer	9.82e-06	0.000118	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.81e-06	0.000117	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—thyroid cancer	9.81e-06	0.000117	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—thyroid cancer	9.15e-06	0.00011	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—thyroid cancer	9.12e-06	0.000109	CbGpPWpGaD
Probenecid—ABCC1—Disease—KRAS—thyroid cancer	9.02e-06	0.000108	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—thyroid cancer	8.99e-06	0.000108	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HRAS—thyroid cancer	8.6e-06	0.000103	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTEN—thyroid cancer	8.56e-06	0.000103	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTEN—thyroid cancer	7.98e-06	9.56e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.92e-06	9.48e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—thyroid cancer	7.83e-06	9.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—thyroid cancer	7.78e-06	9.32e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—HRAS—thyroid cancer	7.66e-06	9.18e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—thyroid cancer	7.59e-06	9.09e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—thyroid cancer	7.23e-06	8.66e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—thyroid cancer	6.99e-06	8.37e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—thyroid cancer	6.82e-06	8.16e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—thyroid cancer	6.77e-06	8.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—RXRA—thyroid cancer	6.65e-06	7.97e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—thyroid cancer	6.37e-06	7.63e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—thyroid cancer	6.3e-06	7.54e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.16e-06	7.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—thyroid cancer	6.12e-06	7.33e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—thyroid cancer	5.67e-06	6.79e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.5e-06	6.58e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTEN—thyroid cancer	5.37e-06	6.43e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—thyroid cancer	5.36e-06	6.42e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTEN—thyroid cancer	5.34e-06	6.39e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.01e-06	6e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—thyroid cancer	4.94e-06	5.91e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTEN—thyroid cancer	4.79e-06	5.74e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTEN—thyroid cancer	4.68e-06	5.6e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—thyroid cancer	4.6e-06	5.51e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTEN—thyroid cancer	4.37e-06	5.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—thyroid cancer	4.2e-06	5.03e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.31e-06	3.96e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—thyroid cancer	3.09e-06	3.71e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—thyroid cancer	3.08e-06	3.68e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTEN—thyroid cancer	2.88e-06	3.45e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—thyroid cancer	2.76e-06	3.31e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—thyroid cancer	2.7e-06	3.23e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—thyroid cancer	2.52e-06	3.02e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—thyroid cancer	1.66e-06	1.99e-05	CbGpPWpGaD
